Skip to main content
Cardiosense Recieves FDA De Novo Classification for Novel Cardiac Technology Designed to Improve Care for Patients with Heart Failure Read the press release

Media Coverage

Dr. Omer Inan shares insight on academia and entrepreneurship – for example, how do they interact…and can a person pursue both?

Keep reading